Prediction of reversible myocardial dysfunction by positron emission tomography, low-dose dobutamine echocardiography, resting ECG, and exercise testing

Citation
H. Wiggers et al., Prediction of reversible myocardial dysfunction by positron emission tomography, low-dose dobutamine echocardiography, resting ECG, and exercise testing, CARDIOLOGY, 96(1), 2001, pp. 32-37
Citations number
31
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CARDIOLOGY
ISSN journal
00086312 → ACNP
Volume
96
Issue
1
Year of publication
2001
Pages
32 - 37
Database
ISI
SICI code
0008-6312(2001)96:1<32:PORMDB>2.0.ZU;2-8
Abstract
We studied different algorithms to identify patients with heart failure who could potentially benefit from revascularization. Thirty-five coronary art ery bypass (graft) patients with an ejection fraction of 35 +/- 7% underwen t preoperative F-18-fluoro-2-deoxyglucose positron emission tomography (PET ), low-dose dobutamine echocardiography (LDDE), and exercise testing. Follo w-up by echocardiography and coronary angiography was performed 6 months af ter coronary artery bypass grafting. The sensitivity for prediction of reve rsible myocardial dysfunction was highest for PET and for ST depression or angina pectoris during exercise testing (100 and 93%, p = NS), 71% for LDDE (p < 0.05 vs. PET), and 50% for resting ECG (p < 0.02 vs. PET and exercise test). The specificity did not differ between LDDE (81%), PET (67%), and r esting ECG (71%), but was lowest for exercise testing (33%; p < 0.02 vs. PE T, LDDE, and resting ECG). Accuracies were: PET 80%, LDDE 77%, exercise tes ting 62%, and resting ECG 58% (p < 0.05 vs. PET). In patients with a negati ve exercise test, recovery was unlikely, and further viability testing may not be needed. In patients with a positive test, recovery may occur, and ad ditional PET or LDDE should be performed. In these cases, PET with an F-18- fluoro-deoxyglucose uptake of greater than or equal to 70% as the criterion for viability yields optimum diagnostic characteristics. This strategy awa its further evaluation in larger patient populations with heart failure. Co pyright (C) 2001 S. Karger AG, Basel.